Which topical agents are recommended as adjunctive therapy for a 72‑year‑old man with thoracic herpes zoster who is already receiving oral valacyclovir and systemic pain control?

Topical Agents as Adjunctive Therapy for Herpes Zoster

For a 72-year-old patient with thoracic herpes zoster already on oral valacyclovir and systemic pain control, topical lidocaine patches are the primary evidence-based topical adjunctive therapy recommended, with topical capsaicin as an alternative option for postherpetic neuralgia if it develops.

Primary Topical Recommendations

Topical Lidocaine Patches

• First-line topical agent for zoster-associated pain and postherpetic neuralgia (PHN) 1, 2
• Applied directly to the affected dermatome
• Provides localized analgesia without systemic side effects
• Particularly valuable in elderly patients like this 72-year-old, who may be more susceptible to systemic medication side effects

Topical Capsaicin

• Alternative topical option for pain management 3
• More commonly used for established PHN rather than acute herpes zoster
• Can reduce pain intensity but may cause initial burning sensation

Experimental and Emerging Topical Options

Topical Corticosteroid Combination

The evidence suggests that topical acyclovir/hydrocortisone cream has shown clinical benefit by limiting inflammation 4. However, this requires frequent application (5-6 times daily), making it less practical than oral antivirals. This combination addresses both viral replication and the inflammatory cascade that contributes to pain.

Important caveat: This patient is already on oral valacyclovir, which is superior to topical antivirals, so adding topical acyclovir would provide minimal additional benefit.

Topical Ozone Therapy

Recent evidence suggests topical ozone (via hydrotherapy and ozonated oil) may help relieve pain and shorten disease course 5. However, this is based on limited evidence and is not widely available in standard practice.

Supportive Topical Care

Basic Wound Care

• Topical mupirocin 2% ointment twice daily for prevention of secondary bacterial infection 5
• Good skin care practices to promote healing 2
• Keep lesions clean and dry

What NOT to Use

Topical antivirals alone are NOT recommended as primary therapy because:

• They do not reach the site of viral reactivation in the dorsal root ganglia 4
• They are inferior to oral antivirals for herpes zoster
• This patient is already receiving appropriate oral valacyclovir

Clinical Algorithm for This Patient

Given this 72-year-old is already on oral valacyclovir and systemic pain control:

1. Add topical lidocaine patches to the affected thoracic dermatome for localized pain relief
2. Apply topical mupirocin if there are signs of secondary bacterial infection or broken vesicles
3. Monitor for PHN development (pain persisting >90 days after rash onset)
4. If PHN develops, continue lidocaine patches and consider adding capsaicin cream as adjunctive therapy

Critical Timing Consideration

The patient is already receiving oral valacyclovir, which should have been initiated within 72 hours of rash onset for optimal efficacy 6, 2. The topical agents serve as adjunctive pain management, not antiviral therapy. At age 72, this patient has a 10-20% risk of developing PHN 7, making aggressive pain control essential.

Safety Profile

Topical agents have minimal systemic absorption and are generally well-tolerated in elderly patients, making them ideal adjuncts to oral therapy in this 72-year-old patient who may be on multiple medications.